1 / 16

Pharmacogenomics: Genotype specific response to a weight loss drug

Pharmacogenomics: Genotype specific response to a weight loss drug. Paper by Hauner et al. Pharmacogenetics 2003; 13(8): 453-459 Presented by: Payal Sipahimalani. The drug: Sibutramine. Chemical name: Sibutramine hydrochloride monohydrate Used for management of obesity (BMI ≥ 30kg/m 2 )

Download Presentation

Pharmacogenomics: Genotype specific response to a weight loss drug

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Pharmacogenomics: Genotype specific response to a weight loss drug Paper by Hauner et al. Pharmacogenetics 2003; 13(8): 453-459 Presented by: Payal Sipahimalani

  2. The drug: Sibutramine • Chemical name: Sibutramine hydrochloride monohydrate • Used for management of obesity (BMI≥30kg/m2) • Mode of action: Inhibits uptake of serotonin, dopamine and norepinephrine • Side effects may include headache, dry mouth, anorexia, constipation, insomnia, dizziness, nausea, nervousness, dyspepsia, increase in blood pressure and heart rate.

  3. Sibutramine • Variability in response • Reasons unknown • Ideally: want to be able to identify responders

  4. This study • G-protein b3 subunit gene (GNB3) • C825T polymorphism • Alternative splicing • Truncated, but functional protein variant • Increased signal transduction • Associated with obesity • Association between C825T status and treatment outcome?

  5. Study design Previous study: • 348 subjects (BMI: 30 - 40) • 174 = sibutramine group • 174 = placebo group • Weight loss after 54 weeks This study: • Genotyped the C825T polymorphism – pyrosequencing • 111 individuals

  6. Genotype distribution • 825T frequency = 35.1% in entire group • Higher than in non-obese subjects

  7. Sibutramine vs. placebo • Mean weight loss: • Sibutramine • 10.3 + 1.0 kg • Placebo • 5.0 + 1.5 kg • Therefore, significantly greater weight loss with sibutramine. Figure 1: Weight loss after 54 weeks

  8. Placebo group Weight loss in: TT = 7.8kg TC = 6.9kg CC = 2.7kg • Genotype specific difference in weight loss • T allele carriers: 4.3 + 2.0 kg greater than CC

  9. 6.9 7.8 7.8 15.6 10.2 2.7 7.1 9.6 Figure 3: Genotype specific weight loss with sibutramine treatment vs. placebo. Sibutramine group • TT and TC – no additional effect with drug • CC – strong effect (P=0.003)

  10. Sibutramine vs. Placebo Odds Ratios (95% Confidence Intervals)

  11. Long term effects Two years after study termination: • No overall advantage of sibutramine over placebo • ≥ 5% weight loss • Placebo group: greater in T carriers • Sibutramine group: greater in CC individuals.

  12. Summary and Conclusions • Polymorphism  drug response? • 825T allele of GNB3 • associated with obesity • Increased weight loss without drug • Sibutramine • increased overall weight loss • Genotype specific weight loss (C>T)

  13. Mechanism of action • 825T allele = intracellular signalling = response to drugs • Not here!!! • set-point for body weight– easily shifted up or down • Handle stress better? • CC individuals defend body weight set point.

  14. Future directions • Side effects  genotype? • Are psychological mechanisms of weight control allele specific? • Other polymorphic genes involved in body weight regulation? • Predict outcome of non-pharmacological and pharmacological programmes of weight loss.

  15. Critique • Ethnicity • variation in frequency of polymorphism • other effects? • Sample size • Graphs and tables

  16. Discussion • Side effects and the lawsuit • Long term effect?

More Related